These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4465781)

  • 1. Trade names or approved names. Part II. Points of view. The pharmaceutical company.
    Hoare RG
    Postgrad Med J; 1974 Feb; 50(580):85-7. PubMed ID: 4465781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trade names or approved names. Part II. Points of view. The department of health.
    Cornah G
    Postgrad Med J; 1974 Feb; 50(580):77-80. PubMed ID: 4465778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trade names or approved names. Part II. Points of view. The retail pharmacist.
    Haberfield GR
    Postgrad Med J; 1974 Feb; 50(580):81-2. PubMed ID: 4465779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trade names or approved names. Part IV. The solution. Introduction.
    Dunlop D
    Postgrad Med J; 1974 Feb; 50(580):121. PubMed ID: 4465772
    [No Abstract]   [Full Text] [Related]  

  • 5. Trade names or approved names. Part 1. The situation Substitution: right or wrong?
    Barfield JC
    Postgrad Med J; 1974 Feb; 50(580):68-70. PubMed ID: 4471371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trade names or approved names. Part 11. Points of view. The general practitioner.
    Venables TL
    Postgrad Med J; 1974 Feb; 50(580):88-90. PubMed ID: 4465782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trade names or proper names? A problem for the prescriber.
    Huskisson EC
    Br Med J; 1973 Oct; 4(5886):225-8. PubMed ID: 4758398
    [No Abstract]   [Full Text] [Related]  

  • 8. Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation.
    Beckett AH
    Postgrad Med J; 1974 Feb; 50(580):125-9. PubMed ID: 4465774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trade names or approved names. Part 1. The situation. Is this a world-wide problem?
    Stevens CC
    Postgrad Med J; 1974 Feb; 50(580):71-2. PubMed ID: 4465776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trade names or approved names. Part III. Special cases. Anti-diabetic drugs.
    Galton DJ
    Postgrad Med J; 1974 Feb; 50(580):112-3. PubMed ID: 4465770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trade names or approved names. Part III. Special cases. Combination products.
    Cromie BW
    Postgrad Med J; 1974 Feb; 50(580):103-6. PubMed ID: 4465768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trade names or approved names. Part 1. The situation. How doctors prescribe and why.
    Teeling-Smith G
    Postgrad Med J; 1974 Feb; 50(580):65-7. PubMed ID: 4465775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trade names or approved names. Part IV. The solution. How should we prescribe?
    Vere DW
    Postgrad Med J; 1974 Feb; 50(580):122-4. PubMed ID: 4465773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cases for and against prescribing generic drugs: don't take innovative research based pharmaceutical companies for granted.
    Cruickshank JM
    BMJ; 1988 Dec; 297(6663):1597-8. PubMed ID: 3147090
    [No Abstract]   [Full Text] [Related]  

  • 15. Pills, potions and persuasion, or the 'medicine explosion'.
    Kane GJ
    S Afr Med J; 1973 Jun; 47(25):1127-8. PubMed ID: 4714712
    [No Abstract]   [Full Text] [Related]  

  • 16. Brand names, generic prescribing, and generic substitution.
    Pincus RC
    Med J Aust; 1983 Jul; 2(2):89-91. PubMed ID: 6679055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Standardization of drug names--a commentary.
    Lee A
    JAMA; 1974 Jul; 229(5):560-2. PubMed ID: 4406903
    [No Abstract]   [Full Text] [Related]  

  • 18. Trade names and generic names. Problems for prescribing physicians.
    Hemminki E; Enlund H; Hellevuo K; Laurila R; Turakka H
    Scand J Prim Health Care; 1984 May; 2(2):84-7. PubMed ID: 6544453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brand names in the pharmacopeia].
    Offerhaus L; Zwieten PA
    Ned Tijdschr Geneeskd; 1977 Aug; 121(35):1366-9. PubMed ID: 895924
    [No Abstract]   [Full Text] [Related]  

  • 20. Are drug proprietary names necessary?
    D'Arcy PF; Hadden DR
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):117-21. PubMed ID: 10967746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.